Squire Patton Boggs has advised Bemis Company, Inc. (NYSE: BMS) on its acquisition of the medical device packaging operations and related services of SteriPack Group, a global manufacturer of sterile packaging solutions for medical device and pharmaceutical applications.
Bemis Company, Inc. is a major supplier of flexible and rigid packaging used by leading food, consumer products, healthcare and other companies internationally. Founded in 1858 and headquartered in Neenah, Wisconsin, Bemis employs approximately 17,500 individuals worldwide. SteriPack Group, founded in 1994, provides cleanroom sterile packaging solutions and contract manufacturing services for many of the world’s medical device, pharmaceutical and allied healthcare industries. The acquisition by Bemis includes a facility in Ireland, as well as packaging production assets in Malaysia and the United States. Under the transaction, which closed April 29, 2016, SteriPack Group will continue to independently own and operate its contract manufacturing services business.
The international team from Squire Patton Boggs advising Bemis Company, Inc., was led by corporate partner Tony Reed and involved corporate, tax, competition, healthcare regulatory, commercial, IP, employment, pensions and real estate lawyers from offices in the UK, France, Poland, Singapore and the US. Counsel for Irish legal matters was provided by LK Shields, with lead partner Richard Curran, and for Malaysian legal matters by Azmi & Associates, with lead partner Serina Abdul Samad.
“We are pleased our multidisciplinary and cross-office team has been able to support Bemis on a valued and strategic acquisition aimed at growing its healthcare packaging business,” said Tony Reed.